Teva Stock Soars on Earnings Beat: Inside Teva’s 2025 Comeback and What’s Next for Investors
Financial Health and Earnings Trends Teva’s financial turnaround appears to be gaining steam, driven by both top-line growth and disciplined cost management. Quarterly revenue has now grown year-over-year for 11 straight quarters Investing, marking a sustained rebound after a difficult past decade. In Q3 2025, revenue rose ~3% YoY (1% in constant currency) to $4.48 B Investing, while adjusted earnings jumped…